Janssen's Rybrevant (amivantamab), a treatment for EGFR exon20 insertion non-small cell lung cancer (NSCLC), a rare form of lung cancer with a poor prognosis, is making its third attempt to get reimbursement in Korea.The drug’s third challenge for insurance coverage comes when the “nominality” of th
Celltrion said Yuflyma (ingredient: adalimumab), a biosimilar referencing Humira, has been included in the formulary of one of the top three pharmacy benefit managers (PBMs) in the U.S. The three largest PBMs in the U.S., which include CVS Health, Express Scripts, and Optum, collectively manage abou
A Seoul court has rejected a request for an enforcement halt of the medical license suspension filed by Kim Taek-woo, chairman of the emergency committee of the Korean Medical Association (KMA), a group of some 130,000 Korean physicians.As things stand now, Kim's license will be suspended from next
NKMAX, a local biotech firm specializing in NK cell therapy, announced plans to file an objection to its potential delisting from the Korea Exchange (KRX).The company, which has been listed on the Kosdaq since August 2018, is facing delisting due to significant operational challenges.On March 5, NKM
GSK's Shingrix, the world's only shingles vaccine that can be given to immunocompromised individuals such as cancer patients, is notorious for causing pain, unlike any other vaccine, from the moment it is given to three to four days afterward.So why is it so painful to receive Shingrix, a recombinan
A research team at the Seoul National University Bundang Hospital (SNUBH) developed an artificial intelligence (AI) model that significantly improves the prediction of mortality rates in patients undergoing extracorporeal membrane oxygenation (ECMO), the hospital said.ECMO, a critical life-support s
Following Somzz, the first digital treatment device (DTx) in Korea, WELT-I has won approval from the Ministry of Food and Drug Safety and has begun to be prescribed to patients. Still, experts point out that expanding DTx prescriptions remains challenging.Better Therapeutics, which has been approved
In the past month, it felt like I was subjecting my body to accelerated aging experiments. For starters, sleep remained elusive. As I've emphasized before, sufficient sleep is crucial for maintaining healthy eating habits and maximizing the benefits of physical activity. Continuous sleep deprivation
AbbVie Korea's psoriatic disease treatment Skyrizi (risankizumab) won approval from the Ministry of Food and Drug Safety (MFDS) on Tuesday for treating moderate-to-severe pustular psoriasis of the hands and feet in adults (18 years and older) who have had an inadequate response to or are intolerant
Kakao Healthcare said it was invited to speak at the Google Cloud Next 2024 Conference.Google Cloud Next Conference, which is currently being held from Tuesday to Thursday (local time) in Las Vegas, U.S., is an annual tech conference hosted by Google Cloud.During the conference, Kakao Healthcare par
GE HealthCare Korea said it has signed a business agreement with LG Electronics and Microsoft Korea to innovate the healthcare industry and develop and build smart hospitals.GE HealthCare Korea CEO Kim Yong-duk, Microsoft Korea CEO Cho Won-woo and LG Electronics Vice President for Business Solutions
KBIOHealth (Osong Medical Innovation Foundation) has set up an office in Japan, raising expectations of cooperation between the two countries’ biotech industries.KBIOHealth said it opened an office (KBIOHealth JAPAN Office) in Shonan iPark, located in Kanagawa Prefecture, and held a signboard-hangin
Doctors from 50 countries will visit Korea amid mounting concern over the increase in medical students and an essential care crisis, as the World Medical Association (WMA) holds its 226th Council meeting in Seoul from April 18 to 20.To commemorate the occasion, the Korean Medical Association (KMA) w
Recent advancements in HIV treatment and prevention, including the roll-out of pre-exposure prophylaxis (PrEP) and the bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) treatment regimen, have highlighted the critical need for ethnic-centered approaches in healthcare.Therefore, understanding
Korea’s main opposition Democratic Party secured a landslide victory in Wednesday's parliamentary election. As conservative President Yoon Suk Yeol and his ruling party are expected to face an uphill battle in the political scene, many now pay attention to whether there will be any change in the gov
Watson & Company's mental wellness electroceutical tool, Pocus, is receiving attention from industry watchers and the public after showcasing its potential at the 2022 Hangzhou Asian Games, where athletes used it to manage stress and improve sleep quality.Pocus is a wearable device that applies neur
"A general material," or "Takes after mom."Obstetricians have made such vague remarks, providing only speculative indirect information to parents who wondered about fetal sex.From now on, however, they can directly tell whether the fetus is a boy or a girl.That’s because the Constitutional Court rec
LifeSemantics said Tuesday that it has received approval from the Ministry of Food and Drug Safety (MFDS) to conduct a confirmatory clinical trial of its cardiovascular risk (hypertension complications) assessment AI software.The clinical trial will be a retrospective analytical study utilizing bloo
Young physicians from overseas have voiced their support for the resignations and allied leave of absence by Korean trainee doctors and medical students protesting the medical school enrollment quota increase.They also called for the Korean government to stop administrative penalties for collective
GI Innovation is accelerating the development of a subcutaneous (SC) formulation of its immuno-oncology candidate GI-102.The company said Tuesday that it has applied for approval to change the IND (investigational new drug) application for the GI-102 phase 1/2a clinical trial to the Ministry of Food
